#United States #Philadelphia #AI Technology #Coreline Soft #Temple Health

Discovering the Future of Lung Cancer Screening

In today's rapidly evolving healthcare landscape, artificial intelligence (AI) is taking significant strides in enhancing diagnostic processes. A prime example of this innovation is the upcoming webinar co-hosted by Coreline Soft and Temple Health. Set to take place on August 1, 2025, at 1:30 PM EST, the session will delve into AI-driven lung cancer screening and broader implications for advanced patient outcomes.

Overview of the Webinar

The webinar, titled AI in Action: How the Temple Lung Center Is Advancing Lung Screening and Patient Outcomes, promises to be a rich source of knowledge on AI's integration into healthcare. Notably, Dr. Gerard Criner, a leading pulmonary expert from Temple, will be showcasing the impactful role of Coreline's acclaimed AVIEW LCS Plus platform, a comprehensive solution that plays a crucial part in early detection strategies for lung diseases.

The Role of AVIEW LCS Plus

AVIEW LCS Plus is an advanced FDA-cleared platform designed to perform multiple functions—from detecting lung nodules to quantifying emphysema and assessing coronary artery calcification—all through a single low-dose CT scan. This revolutionary technology not only refines clinical workflows but also has significant implications for patient care and return on investment for healthcare providers. Dr. Criner emphasizes, “Our goal has always been to bring the most advanced tools to where they matter most—real patients, real decisions.”

The Transformative Power of AI

As the webinar unfolds, it will provide attendees with unprecedented insights into how AI reshapes clinical decision-making, resource allocation, and ultimately, patient experience. Temple Health stands out as a model institution in the Northeast U.S. for adopting AI technologies that extend beyond diagnosis, focusing on scalable, patient-centered care strategies.

AI is not about replacing human judgment; it augments clinical capabilities. This paradigm shift highlights the potential for earlier detection and treatment of lung diseases, enhancing overall healthcare efficiency. Dr. Criner adds, “AI like Coreline's is not replacing clinical judgment, but reinforcing it—enhancing our ability to detect, triage, and treat lung disease earlier and more efficiently.”

Who Should Attend?

The upcoming session is aimed at a variety of professionals within the healthcare sector, including pulmonologists, radiologists, cardiologists, and primary care providers, as well as hospital administrators and stakeholders from the U.S. and Canada. The webinar is free, further promoting accessibility and knowledge sharing across the medical community.

Registration Details

Those interested in participating are encouraged to register in advance via the official registration link. This collaborative effort between Coreline Soft and Temple Health underscores a commitment to advancing lung cancer screening practices, ultimately striving towards improved patient outcomes.

As AI continues to define the next era of healthcare, initiatives like this webinar play a crucial role in disseminating knowledge and fostering an innovative approach to patient care. Don’t miss this opportunity to be at the forefront of medical advancements!

For more information, keep an eye on Coreline Soft’s announcements and consider joining the conversation on AI and healthcare transformation.